Newsroom

Sorted by: Latest

-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2976285937 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 3,500,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2987788580 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 1,000,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

YOUNG & CO'S BREWERY PLC UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  30 January 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 29 January 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel Hun...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2989338616 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 75,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

Merz Therapeutics Appoints Dan Staner as President, Region Europe

FRANKFURT, Germany--(BUSINESS WIRE)--Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerati...
-

Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 29 January 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 29 January 2026 Number of Public Shares Purchased: 19...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2971953364 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 1,500,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2971953281 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 2,000,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2973004232 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 5,000,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

POXEL SA: The Commercial Court of Lyon Approves the Recovery Plan and Brings an End to the Judicial Reorganisation Proceedings

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, announces the discharge from judicial reorganisation proceedings and ratification of the recovery plan by the Commercial Court of Lyon. This decision closes the observation pe...